Hydroxyapatite formation in the presence of proteoglycans of reduced sulfate content: studies in the brachymorphic mouse
- PMID: 1818763
- DOI: 10.1007/BF02555848
Hydroxyapatite formation in the presence of proteoglycans of reduced sulfate content: studies in the brachymorphic mouse
Abstract
Proteoglycans from the brachymorphic (bm/bm) mouse have a reduced sulfate content due to the impaired activity of adenosine phosphosulfate phosphokinase in these animals. X-ray diffraction and infrared analyses of the mineral from the calcified cartilage of the bm/bm mice demonstrate the presence of significantly larger and more perfect hydroxyapatite crystals of lower carbonate to phosphate content than crystals found in the control animals. No differences were seen in the mineral content, crystallite size, CO3:PO4 ratio, or infrared splitting factors measured in the diaphyseal bone from these animals. Electron microscopic examination similarly shows larger, more disorganized crystals in the bm/bm animals' calcified cartilage as contrasted with controls. In vitro, proteoglycan aggregates from these dwarf mice are shown in a collagen gel-growth system to be less effective inhibitors of hydroxyapatite formation and growth than similarly size sulfated proteoglycans from age-matched control animals. The proteoglycans from the control mice were comparable in inhibitory ability to proteoglycan aggregates extracted from fetal bovine epiphyses. The in vitro and in vivo mineral parameters suggest the importance of sulfate for the interaction between proteoglycans and mineral in growth plate calcification.
Similar articles
-
Treatment of proteoglycan aggregates with physeal enzymes reduces their ability to inhibit hydroxyapatite proliferation in a gelatin gel.J Orthop Res. 1992 May;10(3):313-9. doi: 10.1002/jor.1100100302. J Orthop Res. 1992. PMID: 1314895
-
The inhibitory effect of cartilage proteoglycans on hydroxyapatite growth.Calcif Tissue Int. 1984 May;36(3):285-90. doi: 10.1007/BF02405332. Calcif Tissue Int. 1984. PMID: 6205734
-
Proteoglycans and glycosaminoglycans in cartilage from the brachymorphic (bm/bm) mouse.Coll Relat Res. 1985 Mar;5(2):193-204. doi: 10.1016/s0174-173x(85)80040-6. Coll Relat Res. 1985. PMID: 3924471
-
Role of proteoglycan in the provisional calcification of cartilage. A review and reinterpretation.Clin Orthop Relat Res. 1991 Jan;(262):256-80. Clin Orthop Relat Res. 1991. PMID: 1984925 Review.
-
Current concepts of the physiology and biochemistry of calcification.Clin Orthop Relat Res. 1981 Jun;(157):225-57. Clin Orthop Relat Res. 1981. PMID: 7018782 Review.
Cited by
-
The mineral phase of calcified cartilage: its molecular structure and interface with the organic matrix.Biophys J. 2009 Apr 22;96(8):3372-8. doi: 10.1016/j.bpj.2008.12.3954. Biophys J. 2009. PMID: 19383480 Free PMC article.
-
Alterations in glycosaminoglycan concentration and sulfation during chondrocyte maturation.Calcif Tissue Int. 1994 Apr;54(4):296-303. doi: 10.1007/BF00295954. Calcif Tissue Int. 1994. PMID: 7520345
-
Effect of hormone replacement therapy on bone formation quality and mineralization regulation mechanisms in early postmenopausal women.Bone Rep. 2021 Mar 23;14:101055. doi: 10.1016/j.bonr.2021.101055. eCollection 2021 Jun. Bone Rep. 2021. PMID: 33850974 Free PMC article.
-
DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis.J Bone Miner Res. 2005 Dec;20(12):2169-77. doi: 10.1359/JBMR.050815. Epub 2005 Aug 22. J Bone Miner Res. 2005. PMID: 16294270 Free PMC article.
-
Removal of glycosaminoglycans affects the in situ mechanical behavior of extrafibrillar matrix in bone.J Mech Behav Biomed Mater. 2021 Nov;123:104766. doi: 10.1016/j.jmbbm.2021.104766. Epub 2021 Aug 10. J Mech Behav Biomed Mater. 2021. PMID: 34392037 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Molecular Biology Databases